Neurosurgical grade biomaterial, DuraGenTM, offers a promising matrix for protected delivery of neural stem cells in clinical cell therapies
(2019)
Journal Article
Finch, L., Adams, C., Sen, J., Tickle, J., Tzerakis, N., & Chari, D. M. (2019). Neurosurgical grade biomaterial, DuraGenTM, offers a promising matrix for protected delivery of neural stem cells in clinical cell therapies. Future Healthcare Journal, 6(Suppl 1), 76-76. https://doi.org/10.7861/futurehosp.6-1-s76
Aims Transplantation of neural stem cells (NSCs) into sites of neurological injury is being investigated in clinical trials around the world. These important self-renewing and multipotent precursors can generate the major central nervous system cell... Read More about Neurosurgical grade biomaterial, DuraGenTM, offers a promising matrix for protected delivery of neural stem cells in clinical cell therapies.